Investments
Options
Stocks
Crypto
ETFs
Fractional Shares
Cash Sweep
Features
Paper Trade
Charts
Stock Analysis
Level 2 Data
Moomoo Desktop
Market Analysis
Real-time Quotes
Stocks Market
Options Market
Futures Market
ETF Market
Forex Market
Technical Tools
Stock Screener
Heat Map
Earnings Calendar
Institutional Tracker
Trading News
Headlines
Latest News
Financial Calendar
Trending Topics
Video Analysis
Pricing
Pricing
Crypto Pricing
Margin Rate
Promotions
Welcome Bonus
Moomoo Monday
Moomoo Million
Referral Promotion
Transfer Bonus
Reinvestment Bonus
Resources
Strategies and Insights
Blogs
Moomoo Guide
Moomoo Tutorials
Moomoo Lessons
Investment Courses
Moomoo Community
Feed
Discussions
Support
About Us
About moomoo
Moomoo Highlights
Influencer Program
Investor Relations
You will leave moomoo.com and for FUTU holdings Ltd. website.
More
Support
About Us
About moomoo
Moomoo Highlights
Influencer Program
Investor Relations
You will leave moomoo.com and for FUTU holdings Ltd. website.
Log in
English
中文繁體
中文简体
Download
Mobile
moomoo Desktop
The next-gen workspace
Download now
Click to view more download content
Sign up/Log in
English
Back
Investments
Options
Stocks
Crypto
ETFs
Fractional Shares
Cash Sweep
Features
Paper Trade
Charts
Stock Analysis
Level 2 Data
Moomoo Desktop
Market Analysis
Real-time Quotes
Stocks Market
Options Market
Futures Market
ETF Market
Forex Market
Technical Tools
Heat Map
Earnings Calendar
Institutional Tracker
Trading News
Headlines
Latest News
Financial Calendar
Trending Topics
Video Analysis
Pricing
Pricing
Crypto Pricing
Margin Rate
Promotions
Welcome Bonus
Moomoo Monday
Moomoo Million
Referral Promotion
Transfer Bonus
Reinvestment Bonus
Resources
Strategies and Insights
Blogs
Moomoo Guide
Moomoo Tutorials
Moomoo Lessons
Investment Courses
Moomoo Community
Feed
Discussions
Support
About Us
About moomoo
Moomoo Highlights
Influencer Program
Investor Relations
You will leave moomoo.com and for FUTU holdings Ltd. website.
English
中文繁體
中文简体
Dark
Light
Download
Open Account
Log in to access Online Inquiry
Back to the Top
Teddy123
Female
ID: 102322645
Just exploring the app to grow my money. Don't scold me if I'm copying u k 😂
Follow
48
Following
993
Followers
3901
Visitors
Recommended Users
See More
Movers and Shakers
Recommend to you
51K followers
Follow
bullbull888
You may be interested
1849 followers
Follow
Dadacai
Love to share useful tips
31K followers
Follow
All
Original
Teddy123
commented on a stock
·
23m
Connect Biopharma’s Exclusive Licensee in China, Simcere Pharmaceutical, Announced Submission of its New Drug Application for Rademikibart for the Treatment of Atopic Dermatitis in China
$Connect Biopharma (CNTB.US)$
New Atopic Dermatitis Treatment Could Reach 70 Million Chinese Patients as Connect Biopharma's Partner Files NDA
Translate
Report
Teddy123
commented on a stock
·
24m
Case Study: CyPath® Lung Detects Stage 1A Lung Cancer in High-Risk Patient with Inconclusive Imaging
$bioAffinity Technologies (BIAF.US)$
Revolutionary Lung Cancer Test Succeeds Where PET Scans Failed: Stage 1A Detection Breakthrough
Translate
Report
Teddy123
commented on a stock
·
49m
Celularity & Fountain Life Announce Partnership to Deliver Stem Cell Therapies Under New Florida Law
$Celularity (CELU.US)$
Florida's New Stem Cell Law: Celularity and Fountain Life Team Up to Revolutionize Patient Care
Translate
Report
Teddy123
commented on a stock
·
50m
Alpha Modus Awarded New U.S. Patent Strengthening Its AI Retail Technology Portfolio
$Alpha Modus Holdings (AMOD.US)$
Alpha Modus Lands Game-Changing AI Retail Patent, Eyes Multi-Million Dollar Deals with Fortune 500
Translate
Report
Teddy123
commented on a stock
·
51m
Helius Medical Technologies, Inc. Compliant with Nasdaq’s Continued Listing Requirements
$Helius Medical Technologies (HSDT.US)$
Just Confirmed: Helius Medical Secures Complete Nasdaq Compliance, Clearing Both Equity and Price Requirements
1
1
Translate
Report
Teddy123
commented on a stock
·
52m
Salarius Pharmaceuticals’ Seclidemstat Demonstrates Supporting Role in Inhibiting Validated Oncology Target LSD1 in Two Recently Published Studies
$Salarius Pharmaceuticals (SLRX.US)$
Breakthrough Studies Support Salarius Cancer Drug Effectiveness While Clinical Trials Show Promise
Translate
Report
Teddy123
commented on a stock
·
55m
MetaVia Doses First Patient in the 48 mg MAD Cohort of Its Phase 1 Clinical Trial Evaluating DA-1726 for the Treatment of Obesity to Further Explore Maximum Tolerated Dose
$MetaVia (MTVA.US)$
MetaVia's Novel Obesity Drug Achieves 4.3% Weight Loss Without Titration, Outperforming GLP-1 Tolerability
Translate
Report
Teddy123
commented on a stock
·
56m
Moleculin Expands Phase 3 MIRACLE Clinical Trial into the Country of Georgia, Enrollment Update and Future Plans
$Moleculin Biotech (MBRX.US)$
Moleculin's Phase 3 AML Treatment Trial Gains Momentum: 7 Patients Treated, 16 New Sites Coming
1
1
Translate
Report
Teddy123
commented on a stock
·
1h
Ocean Power Technologies Installs AI Capable Merrows™ PowerBuoy® for Naval Postgraduate School
$Ocean Power Technologies (OPTT.US)$
Advanced AI-Powered Ocean Buoy Strengthens U.S. Navy Maritime Defense with AT&T 5G Technology
Translate
Report
Teddy123
commented on a stock
·
1h
Classover Increases Solana (SOL) Holdings by 295%, Surpasses 50,000 SOL Tokens in Treasury Reserve
$Classover Holdings (KIDZ.US)$
Solana Gets Major Institutional Boost: Classover Grows Holdings 295% to 52,067 SOL, Stakes for Yield
Translate
Report
No content yet
Loading Failed
Refresh now
Loading...
Loading...
No visitors yet
Loading Failed
Refresh now
Can't view the content due to the user's privacy settings